Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance

  title={Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance},
  author={Olivia Samotus and Jack Lee and M. Jog},
  journal={Journal of Neurology},
BackgroundBotulinum toxin type A (BoNT-A) injections is the accepted first-line therapy for cervical dystonia (CD), however, numerous patients discontinue treatment early due to perceived sub-optimal relief. To improve BoNT-A therapy for CD, proper assessment of neck motion and selection of relevant muscles and dosing must be met. Kinematic technology may improve treatment outcomes by guiding physicians to better tailor muscle selection and BoNT-A dosing for CD therapy.Methods28 CD participants… Expand
Developing a Consistent, Reproducible Botulinum Toxin Type A Dosing Method for Upper Limb Tremor by Kinematic Analysis
The kinematic-based dosing method provided consistency in dose selection and subsequent tremor reduction and can be used to standardize tremor assessments for whole-arm tremor treatment planning. Expand
Cervical dystonia: an update on therapeutics
This article focuses on the current understanding and advances in the therapeutics for cervical dystonia and comprehensively reviewed the literature on various treatment options including physiotherapy, oral medications, botulinum toxin injections, and surgery. Expand
Botulinum Toxin in Movement Disorders: An Update
A comprehensive review of the literature provides a critical review of evidence-based clinical trials and highlights recent innovative pilot studies in BoNT research with a focus on novel applications in the treatment of movement disorders. Expand
New modalities and directions for dystonia care
There are two main axes to improve dystonia care; one is non-invasive neuromodulation, such as transcranial magnetic stimulation, transcranIAL electrical stimulation, and transcutaneous electrical nerve stimulation and the other is a quantitative evaluation of dySTONia using a wearable device and motion-capturing system, which can be empowered by artificial intelligence. Expand


Effective Management of Upper Limb Parkinsonian Tremor by IncobotulinumtoxinA Injections Using Sensor-based Biomechanical Patterns
Kinematics is a simple method for standardizing assessments and treatment of upper limb Parkinson’s disease tremor, thereby personalizing tremor therapy and optimizing the effect of BoNT-A injections for Parkinson's disease treMor. Expand
Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes
The results indicate that the majority of unsatisfactory responses to BoNT treatment of CD were caused by correctible factors and imply a need for improved education regarding optimal treatment methods. Expand
Botulinum Toxin Therapy for Cervical Dystonia: The Science of Dosing
Ongoing studies, such as the Cervical Dystonia Patient Registry for Observation of BOTOX® Efficacy (CD PROBE), may help clarify the question of optimal dosing intervals for BoNT-A in CD. Expand
Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia
This pilot study suggests that multichannel electromyographic mapping may result in improved efficacy in the treatment of antibody-negative onabotulinumtoxinA refractory CD. Expand
Botulinum toxin type A with or without needle electromyographic guidance in patients with cervical dystonia
CD patients treated with EMG guidance experienced a prolonged benefit as measured by the Tsui scale when compared to CD patients treating with palpation guidance alone, which resulted in a lower incidence of dysphagia and higher incidence of discomfort at the injection site than palpation-guided injection. Expand
British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
In both scenarios, a holistic approach including drug treatment, retraining and psychological support is valuable in the management of these complex and severe cervical dystonia. Expand
Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns – A New Future
Kinematic tremor assessments provide the injector unique insight to objectively individualize and personalize injection parameters demonstrating BoNT-A effectively alleviates functional disability caused by essential tremor. Expand
Botulinum toxin type A therapy for cervical dystonia.
Only adverse events clearly associated with the mechanism of action of BtA were more frequent in the treatment group, and enriched trials (using patients previously treated with BTA), suggest that further injection cycles continue to work for most patients. Expand
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement
An international group of expert neurologists, experienced in BoNT treatment, met to review the literature and pool their extensive clinical experience to give practical guidance about treatment of CD with BoNT. Expand
Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia.
Optimal treatment may involve a combination of oral pharmacologic treatment with BoNTs to maintain the use of lowest possible dosing and to extend effectiveness to the recommended 3-month dosing interval. Expand